$WGRX News

Wellgistics Health Announces Recent Lock-Up Deal To Limit Available Shares; Warrants Exercised To Offer Financing Through 2029

Wellgistics Health Announces Holders Of 1,333,930 Common Shares Agree To Minimum 90-Day Lock-Up Agreement

Why Wellgistics Health (WGRX) Stock Fell Over 24% After Hours?

Wellgistics Health Announces 1-For-50 Reverse Stock Split Effective On May 26, 2026

Wellgistics Health Q1 EPS $(0.07) Up From $(0.62) YoY, Sales $1.559M Down From $10.863M YoY

Wellgistics Health Withdraws Preliminary Proxy Statement, Continues To Evaluate Potential Strategic Transactions

Wellgistics Health Announces Pilot Collaboration With Kare PharmTech And Kare Clinicals Integrating Its MSO Infrastructure To Support CCM And RPM Services Across Participating Provider Offices

Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

Wellgistics Health shares are trading higher after the company announced a partnership with KareRX to build AI platforms for faster prescription access.

Wellgistics Health shares are trading higher after the company announced a partnership with KareRX to build AI platforms for faster prescription access.

Wellgistics Health Partners With KareRx To Build AI Platform For Faster Prescription Access

Penny Stock Wellgistics Health Ends Silverback Deal, Cuts Dilution Risk

Wellgistics Health shares are trading higher after the company announced it terminated the Settlement Agreement with Silverback Capital

Wellgistics Health shares are trading higher after the company announced it terminated the Settlement Agreement with Silverback Capital

Wellgistics Health Terminates Settlement Agreement And Stipulation With Silverback Capital

Wellgistics Health, Inc. (WGRX) Explores $105M Acquisition of Neuritek to Expand Healthcare Platform

Thunder Rock Capital Serves as Exclusive M&A Advisor to Neuritek Therapeutics, Inc. on $105,000,000 Proposed Acquisition by Wellgistics Health, Inc.

Why Are Shares Of Wellgistics Health Falling?

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

Wellgistics Health shares are trading lower after the company announced it entered into non-exclusive, non-binding Letter of Intent to evaluate a potential acquisition of Neuritek Therapeutics.